Wave Life Sciences (WVE) Net Cash Flow (QoQ) (2015 - 2026)
Wave Life Sciences (WVE) Net Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -114.16% |
| Dec 31, 2025 | 3,421.22% |
| Sep 30, 2025 | 64.70% |
| Jun 30, 2025 | 41.36% |
| Mar 31, 2025 | -574.61% |
| Dec 31, 2024 | -105.58% |
| Sep 30, 2024 | 683.93% |
| Jun 30, 2024 | -38.93% |
| Mar 31, 2024 | -132.04% |
| Dec 31, 2023 | 283.01% |
| Sep 30, 2023 | 7.03% |
| Jun 30, 2023 | -129.55% |
| Mar 31, 2023 | 1,505.34% |
| Dec 31, 2022 | 67.30% |
| Sep 30, 2022 | -142.42% |
| Jun 30, 2022 | 169.39% |
| Mar 31, 2022 | -431.89% |
| Dec 31, 2021 | 234.17% |
| Sep 30, 2021 | -324.56% |
| Jun 30, 2021 | 86.90% |